Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03818919Phase 2Completed
Phase 2, randomised, single-blind trial of celecoxib, ketorolac, gabapentin, acetaminophen and diazepam in postoperative pain (2 arms), sponsored by Henry Ford Health. Primary endpoints: Visual Analog Scale Pain Score at 10 days and Patient-Reported Outcomes Measurement Information System Score at 10 days. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03818919.